ASG

----

Weekly Recap | Credo Tech +0.95%, consensus target above spot

LongbridgeAII'm LongbridgeAI, I can summarize articles.

Credo Tech finished the week up 0.95% at $232.75, ahead of the S&P 500’s 0.49% gain by about 0.46 percentage points. The stock swung in a wide 14.79% range, tracing a clear dip-then-rebound pattern: Monday (24 Aug) opened lower and touched $211.50, then prices stabilised over the next two sessions. Thursday (27 Aug) saw a surge to $244.46 on heavier volume before Friday (28 Aug) pulled back to close at $232.75. Average daily volume for the week was around 3.

The Week

Credo Tech finished the week up 0.95% at $232.75, ahead of the S&P 500’s 0.49% gain by about 0.46 percentage points. The stock swung in a wide 14.79% range, tracing a clear dip-then-rebound pattern: Monday (24 Aug) opened lower and touched $211.50, then prices stabilised over the next two sessions. Thursday (27 Aug) saw a surge to $244.46 on heavier volume before Friday (28 Aug) pulled back to close at $232.75. Average daily volume for the week was around 3.39m shares, roughly 49% below the 60-day median, pointing to a relatively thin tape.

Key Events

The dominant thread this week was the fallout from an earnings miss and subsequent analyst downgrades, followed by a rebound. On Monday pre-market, reports of weak results and rating cuts sent the stock down as much as 8% intraday. Selling continued into Tuesday, with another 3% dip at one point. Sentiment began to shift on Wednesday, as Mizuho named Credo among AI names tied to a $500B data-centre financing push, and the company announced its annual general meeting. Thursday brought a strong recovery, with the stock climbing 7% to $242.50 intraday as several brokers maintained moderate buy ratings. Friday added another 4% intraday move to $234.69 before the close faded. Two material filings hit this week: a DEF 14A and an ARS submitted on 26 Aug, both routine quarterly disclosures.

Analyst Ratings

As of this week, 19 brokers cover Credo Tech. Of these, 14 rate it a buy, 4 rate it overweight, 1 rates it hold, and none rate it underweight or sell. The consensus rating is strong buy, with a consensus target of $283.23, roughly 21.69% above this week’s close. Target prices span a wide band from $184 at the low end to $350 at the high end, pointing to meaningful disagreement on valuation. Within the semiconductor sector of 77 covered names, Credo ranks 19th by analyst coverage, placing it in the upper-middle tier.

The Week Ahead

The key event next week is Credo’s fiscal Q1 2027 earnings release after the close on Tuesday, 1 Sep. Consensus estimates call for EPS of $0.89 and revenue of $472m. This week’s swings were already tied to expectations around the prior quarter, so whether the upcoming print meets or beats those numbers will be central to whether the rebound holds. On the macro side, 1 Sep brings final S&P Global manufacturing PMI, ISM manufacturing PMI and JOLTS job openings, followed on 2 Sep by ADP private payrolls, factory orders and weekly EIA crude inventories.

In Short

Credo Tech absorbed an earnings miss and analyst downgrades early in the week, then rebounded to close slightly higher on light volume, suggesting the market still gives the company credit for its longer-term AI data-centre story. The rating backdrop is constructive, with a strong buy consensus and a target above spot, though the wide target range reflects real disagreement. Valuation sits high at about 91.9x P/E and 21x P/B. In the latest session, large-lot money was a net buyer while smaller flows were net sellers, leaving direction mixed. Next week’s quarterly report is the main test of whether the current valuation and recovery can be sustained.

This article is generated by LongbridgeAI from market data, for information only and not investment advice.

Login to unlock2,762characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.